Content of an Audit Trail / Must an Audit Trail be printable?

Recommendation
27-29 August 2025
Copenhagen, Denmark
If you book this course together with the course "Raw Data - Understanding, Defining and Managing," we will offer you a discount of € 600,-
The requirements for an audit trail can be found in all relevant regulations. The changes and deletions of data, and in future perhaps also the creation of data, should be tracked in this way. In the new draft of the EU GMP guideline Annex 11, the requirements were described in much greater detail than before. 6 Experts from the pharmaceutical industry and from inspectorates answer an extensive list of questions in this context, focusing on the currently valid Annex 11.
Question 1: From the regulators' or inspectors' point of view, is there a minimum requirement for what must be included in an audit trail?
Information regarding the expectations of the inspectors can be found in the Aide Memoire 'Supervision of Computerised Systems' of the EFG 11 (only as a German version available), which is a catalogue of guidelines, questions and recommendations. The document is part of the QA system of the inspectorates in Germany. It serves to harmonise the preparation, implementation and follow-up of an inspection.
The minimum requirements regarding the content of an audit trail are set out in EU GMP Annex 11 and EU GMP Chapter 4:
The following information should be included in an audit trail:
- 'Who changed what, when and how?'
- Original and the changed value
- Reason for the change / deletion
Question 2: Does the audit trail have to be printable?
Everything must always be printable. This results from EU GMP Guide Annex 11: 8 - Printouts
- 8.1 - It should be possible to obtain clear printed copies of electronically stored data.
- 8.2 - For records supporting batch release it should be possible to generate printouts indicating if any of the data has been changed since the original entry.
The Expert Team:
Klaus Feuerhelm, Local GMP Inspectorate / Regierungspräsidium Tübingen
Eberhard Kwiatkowski, PharmAdvantageIT, Neuschoo
Dr Ullrich Opitz, Merck, Darmstadt
Yves Samson, Kereon, Basel
Dr Wolfgang Schumacher, ehem. F. Hoffmann-La Roche, Basel
Dr Arno Terhechte, Local GMP Inspectorate / Bezirksregierung Münster
Related GMP News
09.07.2025Drafts of EU GMP Guideline Annex 11, Annex 22 and Chapter 4 released for comment
20.03.2025New FDA-Guidance for Industry draft on AI
12.02.2025Cloud Computing: Documents for a smooth migration to the cloud
15.01.2025Cloud Computing: Open or Closed System according to 21 CFR Part 11?
11.12.2024Cloud Computing: Validation documents for a SaaS application